A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors

1. Duca, M.
2. Lim, D.W.-T.
3. Subbiah, V.
4. Takahashi, S.
5. Sarantopoulos, J.
6. Varga, A.
7. D'Alessio, J.A.
8. Abrams, T.
9. Sheng, Q.
10. Tan, E.Y.
11. Rosa, M.S.
12. Gonzalez-Maffe, J.
13. Sand-Dejmek, J.
14. Fabre, C.
15. Martin, M.